Ameriprise’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
Other funds holding CRBU
KCM
Ameriprise's CRBU Position: Q3 2026 in Review
Ameriprise sold out of Caribou Biosciences (CRBU) in Q3 2026, closing a stake of 29,530 shares — an estimated $52K sold.
Ameriprise first reported a position in CRBU in Q3 2022 and held it in 14 quarters. The position peaked at $649K in Q4 2024. 147 funds tracked by Wall St. Rank hold CRBU as of Q3 2026.
- Ameriprise reported no remaining Caribou Biosciences position as of Q3 2026 after selling out during the quarter.
- Ameriprise sold 29,530 Caribou Biosciences shares in Q3 2026, an estimated $52K.
- Ameriprise first reported a position in Caribou Biosciences in Q3 2022 and held it in 14 quarters.
- Ameriprise's Caribou Biosciences position peaked at $649K in Q4 2024.
- 147 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2026.
Based on Ameriprise's 13F filing for Q3 2026, filed 16 Nov 2026.